A Study of Oral Ladarixin in Recent Onset Type 1 Diabetes and a Low Residual β-cell Function

Clinical trial NCT04628481 · TERMINATED

Trial details

NCT number: NCT04628481
Sponsor: Dompé Farmaceutici S.p.A
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Recent Onset type1 Diabetes

Start date: 2021-01-12
Primary completion: 2025-03-31
Enrollment: 141

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.